Please ensure Javascript is enabled for purposes of website accessibility

Health Care

Merck completes $11B Acceleron Pharma acquisition

“This is an important and strategic opportunity for our company to continue growing our cardiovascular portfolio and pipeline, that builds on our long and proud legacy in cardiovascular disease and further bolsters our business development strategy,” said Merck President and Chief Executive Officer Rob Davis of the $11.5 billion deal.

Read More »

Keeping the edge

New Jersey has long enjoyed a reputation as the “medicine cabinet” of the nation. But as health care and technology increasingly overlap, will the Garden State lose its positions to tech powerhouses like Silicon Valley, Boston, and North Carolina’s Research Triangle Park?

Read More »

Going forward

Sarah Hill, who leads sustainability efforts at Franklin Lakes-based BD, speaks with NJBIZ Editor Jeff Kanige about the company’s approach to ESG issues.

Read More »